Today, more than 1 in 7 U.S. adults suffer from chronic kidney disease, a disease that disproportionately affects minority, rural, and low-income Americans. People who work labor-intensive jobs, spending long hours in the heat or sun are at higher risk as well. Their kidneys become damaged and over time this leads to high blood pressure, heart disease, stroke, and early death.

When patients’ kidneys fail, they enter End Stage Renal Disease (ESRD). Two of the critical treatments keeping them alive include: dialysis sessions to clear toxins from the blood and oral-only drugs to lower serum phosphorus levels.

On January 1, 2025, the Center for Medicare & Medicaid Services intends to change the way phosphorus lowering treatments are paid for in Medicare, making it harder for patients to access the range of lifesaving therapy options they need.

Join us in telling Congress to protect patient care and access to innovative therapies.